STUDY SEARCH RESULTS

1 study found for your search request:  8527-004

MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004)
Condition: Human Immunodeficiency Virus
Minimum Age: 18 years, Maximum Age: 60 years
Gender: All
Study ID: NCT05494736
Status: Completed




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site